Axoft
Axoft
A neurotechnology company developing implantable Brain-Computer Interfaces.
About
What does Axoft do?
Axoft is a neurotechnology company focused on developing implantable Brain-Computer Interfaces (BCIs). The company aims to advance the treatment of neurological disorders and enhance human capabilities through its innovative technology. Axoft has raised significant funding to expand its clinical trials globally and pursue U.S. regulatory approval for its BCI technology.
What is Axoft's valuation?
StartupHub estimates Axoft's effective valuation at $233.2M (range $137.5M to $330.0M, 21% confidence), based on comparable companies in the sector.
How much funding has Axoft raised?
Axoft has raised a total of $55M in funding. The most recent round on record is Series A.
Where is Axoft headquartered?
Axoft is headquartered in Cambridge, Massachusetts, USA.
What industry does Axoft operate in?
Axoft operates in Neurotechnology, Biotechnology, Medical Devices, Artificial Intelligence.
No comments yet. Be the first to share your take.